Chapter 25: Cannabinoids and Pain: Clinical Evidence

Authors: MacCallum CA, Eadie L & Narouze SN


In this chapter, we have summarized systematic reviews of randomized controlled trials using cannabis-based medicine for pain, including but not limited to chronic pain (non-cancer pain, neuropathic pain, centralized pain disorders such as fibromyalgia, rheumatic inflammatory pain, cancer pain) and acute pain.

It appears that more consistent methodology is needed among future research designs with regard to cannabis product, dosing, method of intake, timing of administration, pain scale measurements, and how pain is subjectively measured and reported. Without this, it is challenging to compare the breadth of data that now exists on cannabis and its effect on pain.

© 2021 Springer International Publishing

Editors: Narouze, Samer N. (Ed.) MacCallum, Caroline A.

Edition Number: 1

ISBN (Softcover): 978-3-030-69185-1
Due: May 19, 2021

ISBN (eBook): 978-3-030-69186-8
Due: June 16, 2021

DOI: 10.1007/978-3-030-69186-8

Pre-Order Information:

Customers within the U.S. and Canada please contact Springer Customer Service at +1-800-777-4643; Latin America please contact Springer at +1-212-460-1500 (24 hours a day, 7 days a week). Pre-ordered printed titles are excluded from promotions.